INS and Large for gestational age: In neonatal outcomes, Metformin consistently ranks high in every measure, including the surface of the cumulative ranking function values that range from 0.75 to 0.85, demonstrating greater effectiveness in lowering macrosomia, neonatal hypoglycemia, and birth weight when compared with glyburide and insulin.